Investigational Drug Information for Firibastat
✉ Email this page to a colleague
What is the drug development status for Firibastat?
Firibastat is an investigational drug.
There have been 5 clinical trials for Firibastat.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 25th 2020.
The most common disease conditions in clinical trials are Hypertension, Kidney Failure, Chronic, and Ventricular Dysfunction, Left. The leading clinical trial sponsors are Quantum Genomics SA, Eurofins Optimed, and PRA Health Sciences.
There are three US patents protecting this investigational drug and fifty-six international patents.
Summary for Firibastat
| US Patents | 3 |
| International Patents | 56 |
| US Patent Applications | 3 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2020-06-25) |
| Vendors | 28 |
Recent Clinical Trials for Firibastat
| Title | Sponsor | Phase |
|---|---|---|
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) | PRA Health Sciences | Phase 3 |
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) | Quantum Genomics SA | Phase 3 |
| Firibastat in Treatment-resistant Hypertension | Quantum Genomics SA | Phase 3 |
Clinical Trial Summary for Firibastat
Top disease conditions for Firibastat
Top clinical trial sponsors for Firibastat
US Patents for Firibastat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Firibastat | ⤷ Sign Up | Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same | Institute National de la Sante et de la Recherche Medicale (Inserm) (Paris Cedex, FR) | ⤷ Sign Up |
| Firibastat | ⤷ Sign Up | Method for the preparation of (3S, 3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (Paris, FR) | ⤷ Sign Up |
| Firibastat | ⤷ Sign Up | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (Massy, FR) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
